IGF2BP1 accelerates the aerobic glycolysis to boost its immune escape in hepatocellular carcinoma microenvironment
Taken together, this study illustrates IGF2BP1 as a potential therapeutic target in HCC, aiming to disrupt the interplay between aberrant metabolism and immune escape.
Authors
- Xiaobo Wang (ORCID: https://orcid.org/0000-0002-3311-1378)
- Xuxing Ye
- Yanping Chen (ORCID: https://orcid.org/0000-0002-0000-2079)
- Junmei Lin (ORCID: https://orcid.org/0009-0000-0285-8930)
Institutions
- Zhejiang Chinese Medical University (CN)
- Jinhua Central Hospital (CN)
Publication Details
- Journal
- Frontiers in Immunology
- Published
- 2024-11-13
- DOI
- https://doi.org/10.3389/fimmu.2024.1480834
- Citations
- 8
- Primary Topic
- RNA modifications and cancer
- Type
- article
- Field-Weighted Citation Impact
- 1.87